TY - JOUR
T1 - Prognostic Value of the Regional Lymph Node Station in Pancreatoduodenectomy for Ampullary Carcinoma
AU - Takagi, Kosei
AU - Nagai, Yasuo
AU - Umeda, Yuzo
AU - Yoshida, Ryuichi
AU - Yoshida, Kazuhiro
AU - Fuji, Tomokazu
AU - Kumano, Kenjiro
AU - Yasui, Kazuya
AU - Yagi, Takahito
AU - Fujiwara, Toshiyoshi
N1 - Publisher Copyright:
© 2022 International Institute of Anticancer Research. All rights reserved.
PY - 2022/3
Y1 - 2022/3
N2 - Background/Aim: The optimal extent of lymph node dissection for ampullary carcinoma is controversial. The aim of this study was to investigate the efficacy of lymph node dissection for ampullary carcinoma. Patients and Methods: Between 2000 and 2020, a total of 75 patients undergoing radical resection for ampullary carcinoma were included. The efficacy index (EI) was calculated by multiplication of the frequency of lymph node metastasis (LNM) at the station and the 5-year survival rate of patients with metastasis at the station. Results: Out of 75 patients, 14 had LNM. The EI for the peri-pancreatic head (station 13 and 17) and superior mesenteric artery (station 14) lymph node were 4.4 and 3.5, respectively. Whereas the peri-gastric (station 5 and 6), common hepatic artery (station 8), and liver hilum (station 12) lymph node stations had zero EI. Although the number of patients with the station 16 dissected was small (9%), the para-aortic (station 16) lymph nodes had the highest EI of 14.3 despite being distant lymph nodes. Conclusion: We identified the distribution of LNM and survival benefit of lymph node dissection for ampullary carcinoma. Our results suggest that the optimal extent of lymph node dissection for ampullary carcinoma could be reconsidered.
AB - Background/Aim: The optimal extent of lymph node dissection for ampullary carcinoma is controversial. The aim of this study was to investigate the efficacy of lymph node dissection for ampullary carcinoma. Patients and Methods: Between 2000 and 2020, a total of 75 patients undergoing radical resection for ampullary carcinoma were included. The efficacy index (EI) was calculated by multiplication of the frequency of lymph node metastasis (LNM) at the station and the 5-year survival rate of patients with metastasis at the station. Results: Out of 75 patients, 14 had LNM. The EI for the peri-pancreatic head (station 13 and 17) and superior mesenteric artery (station 14) lymph node were 4.4 and 3.5, respectively. Whereas the peri-gastric (station 5 and 6), common hepatic artery (station 8), and liver hilum (station 12) lymph node stations had zero EI. Although the number of patients with the station 16 dissected was small (9%), the para-aortic (station 16) lymph nodes had the highest EI of 14.3 despite being distant lymph nodes. Conclusion: We identified the distribution of LNM and survival benefit of lymph node dissection for ampullary carcinoma. Our results suggest that the optimal extent of lymph node dissection for ampullary carcinoma could be reconsidered.
KW - Ampullary carcinoma
KW - carcinomas of the papilla of Vater
KW - lymph node dissection
KW - outcome
UR - http://www.scopus.com/inward/record.url?scp=85125687896&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125687896&partnerID=8YFLogxK
U2 - 10.21873/INVIVO.12789
DO - 10.21873/INVIVO.12789
M3 - Article
C2 - 35241558
AN - SCOPUS:85125687896
SN - 0258-851X
VL - 36
SP - 973
EP - 978
JO - In Vivo
JF - In Vivo
IS - 2
ER -